<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02549001</url>
  </required_header>
  <id_info>
    <org_study_id>PM1331</org_study_id>
    <secondary_id>2015-000561-31</secondary_id>
    <nct_id>NCT02549001</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis</brief_title>
  <official_title>A Multicenter, Randomized, Double-blind, Parallel, Vehicle-controlled Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Onychomycosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Polichem S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Polichem S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether P-3058 nail solution is a safe and
      effective treatment for onychomycosis.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 20, 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete cure of target great toenail defined as negative KOH microscopy, negative culture for dermatophytes and target nail totally clear.</measure>
    <time_frame>Week 60</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Responder rate of the target toenail, defined as negative KOH microscopy, negative culture for dermatophytes and ≤10% residual involvement of the target toenail.</measure>
    <time_frame>Week 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative culture rate for dermatophytes of the target nail.</measure>
    <time_frame>Week 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mycological cure defined as negative KOH microscopy and negative culture for dermatophytes of the target nail.</measure>
    <time_frame>Week 60</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall safety by recording any AE during the entire study duration and the local tolerability by means of severity scores for skin irritation.</measure>
    <time_frame>Week 60</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">953</enrollment>
  <condition>Onychomycosis</condition>
  <arm_group>
    <arm_group_label>P-3058 10%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>P-3058 10%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>vehicle of P-3058 10%</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>vehicle of P-3058 10%</description>
  </arm_group>
  <arm_group>
    <arm_group_label>amorolfine 5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Loceryl®</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>P-3058 10%</intervention_name>
    <arm_group_label>P-3058 10%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vehicle of P-3058 10%</intervention_name>
    <arm_group_label>vehicle of P-3058 10%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>amorolfine 5%</intervention_name>
    <arm_group_label>amorolfine 5%</arm_group_label>
    <other_name>Loceryl®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Patients aged 12 years and older of any race.

          -  Males or females.

          -  Patients with onychomycosis involving ≥ 20% to ≤ 50% of target big toenail.

          -  Patients with a positive KOH examination and culture positive for dermatophyte

        Exclusion Criteria:

          -  Presence of &quot;yellow spikes&quot; on the target nail.

          -  Presence of dermatophytoma on the target nail.

          -  Presence of nail thickness exceeding 2 mm.

          -  Patients with proximal subungual involvement

          -  Patients with severe plantar or moccasin tinea pedis

          -  Patients with nail abnormalities due to other conditions

          -  Patients with life expectancy less than 2 years.

          -  Chemotherapy, immunosuppressive therapy in the 12 weeks prior to Screening visit (V1).

          -  Systemic corticosteroids, antimetabolites and immune-stimulants therapy in the 4 weeks
             prior to Screening visit (V1).

          -  HIV infection or any other immunodeficiency.

          -  Alcohol or substance abuse.

          -  Patients with history of allergic reactions to terbinafine or its excipients.

          -  Woman who is pregnant, nursing an infant, or planning a pregnancy during the study
             period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurizio Caserini, MD</last_name>
    <role>Study Director</role>
    <affiliation>Polichem S.A.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Bulgaria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Various Cities In Iceland</city>
        <country>Iceland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Lithuania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polichem Investigative Site</name>
      <address>
        <city>Multiple Locations</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Bulgaria</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Iceland</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Poland</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
    <country>Sweden</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2015</study_first_submitted>
  <study_first_submitted_qc>September 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2015</study_first_posted>
  <last_update_submitted>March 7, 2018</last_update_submitted>
  <last_update_submitted_qc>March 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Onychomycosis</keyword>
  <keyword>Nail fungus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Onychomycosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amorolfine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

